ZILIA - Key Persons
Job Titles:
- Chairman of the Board
- Leader
Claude is an experienced leader and entrepreneur with 30+ years of experience in life sciences including clinical research, product development, sales, marketing, operations and business development. Claude also worked in the venture capital sector, playing a major role in the financing of numerous ventures.
Job Titles:
- Medical Device Technician
Job Titles:
- Member of the Board of Directors
- Pharmacist - Owner
- President of Gilbert Gobeil Martel Pharmacies
Danny is a pharmacist-owner since 2002 and President of Gilbert Gobeil Martel Pharmacies, which is comprised of four pharmacies and 125 employees. Over the years, Danny has built a strong expertise in marketing, sales and business operations. He is also an active private investor in the healthcare sector.
Job Titles:
- Business Development Director
Job Titles:
- Quality & Regulatory Affairs Specialist
Job Titles:
- Co - Founder
- CTO
- Member of the Board of Directors
Dominic has extensive experience working for the development of new technologies in industrial and academic environments for applications in biotechnology and bioengineering. In addition to being CTO at Zilia, he is associate Professor in the Department of Chemical and Materials Engineering at the University of Alberta. Dominic has a strong background and expertise in academic and industrial bioengineering.
Job Titles:
- Member of the Board of Directors
Dominique is a certified Ophthalmologist and founder of a renowned private medical center. As an active clinical researcher in the field of ophthalmology, she provides valuable knowledge and insight into the development and application of Zilia's technology.
Job Titles:
- Leader
- Member of the Advisory Board
- FRCS ( C ) Assistant Professor at University of Toronto
Dr. Ahmed is a leader in novel treatments for glaucoma, cataract, and lens implant surgery. His pioneering work in glaucoma surgery includes developing micro-invasive glaucoma surgery (MIGS). An assistant professor at the University of Toronto and a professor at the University of Utah, he is also a research director at the Kensington Eye Institute and director of the Glaucoma and Advanced Anterior Segment Surgery (GAASS) fellowship, both at the University of Toronto. In addition, Dr. Ahmed is head of the ophthalmology division at Trillium Health Partners. He is recognized as one of the most experienced complex eye surgeons in the world.
Job Titles:
- Member of the Advisory Board
- Professor at School of Optometry
John G. Flanagan is the Dean and Professor at School of Optometry and Vision Science Program, University of California, Berkeley. Dr. Flanagan graduated in Optometry and Vision Sciences from Aston University, Birmingham, UK in 1980, where he later earned his PhD in 1985. During his career, he has received a multitude of honors for his work including the Certificate of Merit for Research Excellence (Glaucoma Research Society of Canada), the Glenn A Fry Award (American Academy of Optometry), and more recently, the President's Award for services to the profession of optometry (American Optometric Association). He has supervised 45 graduate students and has authored over 175 peer-reviewed publications. In addition, he has 14 book chapters, 3 books and has given numerous invited lectures primarily focusing on ocular imaging to ocular blood flow and vascular reactivity.
Job Titles:
- CEO
- Co - Founder
- Member of the Board of Directors
As a trained optometrist, Patrick puts his in-depth understanding of the clinical care to the development of innovative technologies to revolutionize eye care and prevent vision loss. He is continuously contributing to clinical and innovative technological advancements to the field. Patrick is also a guest speaker at the school of optometry Université de Montréal, the university where he received his Doctor of Optometry (OD) degree and Master's degree in Vision Science. He is an active member of the Association des Optométristes du Québec.
Job Titles:
- Member of the Advisory Board
- President and CEO of Retina Global
Dr. Rajat N Agrawal is President and CEO of Retina Global, a not-for-profit organization addressing retinal diseases in underserved areas of the world, an Adjunct Professor at the Roski Eye Institute, and a Visiting Professor at the Dept. of Ophthalmology at the University of Southern California. He is a world-renowned ophthalmologist and retina specialist. He has been involved in developing a number of medical devices, including the ARGUS-II which allows some blind patients to see again, and drugs for the treatment of ocular diseases. He holds a Masters in Regulatory Affairs and works as a consultant for pre-clinical and clinical research, and business and market evaluation. He has been an advisor for investments and acquisitions of early to late-stage biomed opportunities, totaling over 50 million dollars.
Job Titles:
- Computer Vision Specialist
Job Titles:
- Regulatory Affairs and Quality Director
Job Titles:
- Member of the Board of Directors
- CEO of SBI - Stove Builder International Inc
Marc-Antoine Cantin is CEO of SBI - Stove Builder International inc. Over the years, SBI has acquired multiple competitors. The business now has more than 225 employees and is a North American leader in the fireplace industry. Mr. Cantin is passionate for entrepreneurship and is an active member of Anges Quebec. He is also a member of the Quebec Order of Chartered Professional Accountants.
Job Titles:
- Lead - R & D and Software
Job Titles:
- President at Northern Therapeutics Inc
- Vice President Operations at New World Laboratories
Job Titles:
- Member of the Board of Directors
- Healthtech Entrepreneur & Investor
For the last two decades, Etienne Lagacé has been investing in early-stage medical device and digital health companies (iNovia Capital, Hacking Health Accelerator). Through this experience, he developed a vast business network and a thorough understanding of these sectors. Etienne also co-founded Agile MV, a leading medical device CDMO, and Moonshot Health, a company developing a novel platform harnessing the full potential of in-home ambient signals to create better & safer places to age.